- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
TransCanna Appoints Peter Vitulli Former President of Gatorade to the Board of Directors
TransCanna Holdings Inc. is pleased to announce that Mr. Peter Vitulli has joined the Board of Directors.
TransCanna Holdings Inc. (CSE:TCAN, XETR:TH8) (“TransCanna” or the “Company”) is pleased to announce that Mr. Peter Vitulli has joined the Board of Directors. Mr. Vitulli is currently an operating advisor at Windrose Health Investors and has extensive experience managing start-up enterprises for various investor groups. Earlier in his career Peter was President & General Manager of the $1 billion North American Gatorade business. Mr. Vitulli has over 35 years of experience in the consumer products and healthcare industries with both large corporations and entrepreneurial start-ups. He most recently served as President and CEO of DNA Diagnostics Center, one of the world’s largest providers of private DNA tests.
“I have a long-standing relationship with Peter and look forward to having him on our board. His related experience growing companies and specifically in the medical diagnostic area will help fast track critical decisions to build out our management team and introduce new products.” stated Steve Giblin, TransCanna, President and CEO.
Additionally, Mr. Vitulli served as President and CEO of Sciona, Inc., a pioneering personal genetics company offering customized health and wellness solutions and as President and CEO for Amerifit Nutrition, Inc., a nutritional supplement company focused on women’s health. He holds an MBA from New York University’s Stern School of Business and a BA from Holy Cross College.
“I am really looking forward to joining the TransCanna team. The company is superbly positioned in an exciting market and I believe my business and healthcare experience will help TransCanna aggressively grow to become one of the premier companies in the industry” stated Peter Vitulli.
Mr. Vitulli replaces Mr. Jim Pakulis as director, the company would like to thank Mr. Pakulis for his time with the company and wishes him well in his future endeavors.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.
For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.
On behalf of the Board of Directors,
Steve Giblin
President
604-609-6199
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Click here to connect with Transcanna Holdings Inc. (CSE:TCAN) for an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.